Most clinical and research GHK-Cu protocols sit at 0.52 mg per day subcutaneously, and many patients do not inject every day - 23 injections per week is common for skin and maintenance goals
It wont replace healthy habits, but it strengthens the internal systems that help those habits work
CJC-1295 (no DAC) is a growth hormone-releasing hormone (GHRH) analog that has been studied for its ability to stimulate the pituitary gland to increase natural growth hormone (GH) and IGF-1 secretion
Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP
Split dosing becomes valuable when single dosing produces inconsistent results, when doses above 400mcg are needed, or when evening administration fits better into lifestyle patterns